Read Gene

Read Gene Operating Expenses

The Total Operating Expenses of Read Gene (RDG.WA) as of Oct 17, 2026 is 2.92 M PLN. In the previous year, Total Operating Expenses was 1.64 M PLN — a change of 78.00% (higher).

Operating Expenses

2.92 MPLN

YoY

78.00%

Last updated:

Total Operating Expenses of Read Gene is 2021 2.92 M PLN. Total Operating Expenses of Read Gene was 2020 1.64 M PLN. It decreases by 78.00% higher compared to the previous year.

The Read Gene Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2014
950,000.00 PLN
Jan 1, 2015
1.27 M PLN
Jan 1, 2016
1.74 M PLN
Jan 1, 2017
1.65 M PLN
Jan 1, 2018
1.60 M PLN
Jan 1, 2019
1.63 M PLN
Jan 1, 2020
1.64 M PLN
Jan 1, 2021
2.92 M PLN
The Read Gene Operating Expenses history
YEAROperating ExpensesYoY
2.92 MPLN+78.00%
1.64 MPLN+0.66%
1.63 MPLN+2.13%
1.60 MPLN-3.40%
1.65 MPLN-5.02%
1.74 MPLN+36.66%
1.27 MPLN+34.10%
950,000.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Read Gene Stock analysis

What does Read Gene do? Read Gene SA is a biotechnology company based in Szczecin, Poland, operating within the Health Care sector. The company went public via an IPO on February 12, 2009, and is listed under the ticker RDG.WA with ISIN PLRADGN00014. Read Gene SA focuses on medical research and testing, particularly in the fields of chemoprevention, clinical trials, and genetic testing. Its services include specialized tests for breast cancer, colon cancer, and prostate cancer, alongside medical consultancy and DNA testing. The company also provides DNA-related supplements. It operates one wholly owned subsidiary, Dieta Antyrakowa Read-Gene Sp. z o.o., and its major shareholder is GEN-PAT-MED Sp. z o.o. The company's headquarters are located in Szczecin, within the West Pomeranian Voivodeship. Read Gene SA's activities are centered on developing technologies aimed at detecting, preventing, and treating malignant tumors. The company's website is https://read-gene.com/. No additional details regarding founding year, specific products, or financial figures are provided in the source material. Read Gene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Read Gene stock

Total Operating Expenses of Read Gene is 2.92 M PLN in 2021.

Total Operating Expenses of Read Gene changed from 1.64 M PLN to 2.92 M PLN, representing a 78.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Read Gene since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Read Gene historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Read Gene

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Read Gene